Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 272 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 946. Clear
Clear
Q4
ALKERMES, INC. for ALKERMES, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate
Medicare/Medicaid, Health Issues, Alcohol and Drug Abuse, Tariff (miscellaneous tariff bills)
View →
Q4
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q4
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Medicare/Medicaid, Taxation/Internal Revenue Code, Health Issues
View →
Q4
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q4
TIBER CREEK GROUP for BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid, Budget/Appropriations
View →
Q4
JAZZ PHARMACEUTICALS, INC. for JAZZ PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Pharmacy
View →
Q4
DLA PIPER LLP (US) for BIOTECHNOLOGY INNOVATION ORGANIZATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Pharmacy
View →
Q4
MARSHALL & POPP, LLC for JAZZ PHARMACEUTICALS, INC. AND ITS SUBSIDIARIES, INCLUDING GREENWICH BIOSCIENCES
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $40,000.00 income
Health Issues, Trade (domestic/foreign)
View →
Q4
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
4T
TIDAL BASIN ADVISORS, INC. for YC CONSULTING, LLC ON BEHALF OF PATIENTS RISING NOW
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Defense, Health Issues, Pharmacy
View →
Q4
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View →
Q4
LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $70,000.00 income
Medicare/Medicaid
View →
Q4
LMH STRATEGIC SOLUTIONS for ALKERMES, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $90,000.00 income
Medicare/Medicaid
View →
Q4
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate
Health Issues
View →
3A
LUNDBECK LLC for LUNDBECK LLC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Trade (domestic/foreign), Health Issues, Medicare/Medicaid
View →
Q3
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues
View →
Q3
TODD STRATEGY GROUP for ALNYLAM PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q3
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View →
2A
PFIZER INC. for PFIZER INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q3
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Insurance, Pharmacy
View →
Q3
EMD SERONO, INC. for EMD SERONO INC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Veterans, Defense, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
3T
LONG STRATEGIES, INC. for YC CONSULTING, LLC ON BEHALF OF PATIENTS RISING NOW
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $10,000.00 income
Copyright/Patent/Trademark, Defense, Health Issues, Pharmacy
View →
Q3
DAIICHI SANKYO, INC. for DAIICHI SANKYO INC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Taxation/Internal Revenue Code
View →
Q3
FEROX STRATEGIES for ALEXION PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Health Issues
View →
Q3
SPLITOAK STRATEGIES LLC for CHIESI USA, INC.
3rd Quarter (July 1 - Sep 30) 2025 · North Carolina · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Previous Page 4 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem